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Abstract 
We discuss the assessment and differential diagnoses of a young adult Hungarian man presenting 
with a one-year history of progressive symmetric amyotrophic lateral sclerosis (ALS)-like 
syndrome involving all limbs, tremor of the arms and cerebellar atrophy.  A history of subtle 
sporting difficulty and mild bilateral hand tremor was reported in early adolescence. This remained 
essentially unchanged for 20 years with no limitation of full independent functioning or academic 
achievement to university level.  Examination at current presentation revealed florid fasciculations, 
predominantly proximal muscle weakness and atrophy particularly affecting triceps muscles, brisk 
reflexes, a coarse postural and action tremor of the arms with touch sensitive myoclonus, and a 
wide-based waddling gait.  MRI of brain and spinal cord displayed isolated cerebellar atrophy. 
Formal neuropsychometric testing revealed deficits in attention, processing speed and memory.  
Needle EMG demonstrated widespread chronic denervation whilst nerve conduction studies 
revealed slightly diminished sural sensory action potentials.  White cell enzymes showed markedly 
reduced enzymatic activity of β-Hexosaminidase A. Genetic testing confirmed the presence of two 
heterozygous pathogenic mutations in HEXA gene: [c.1499delT p.(Leu500fs) and c.805G>A 
p.(Gly269Ser)].  The very rare diagnosis of adult onset Tay Sachs disease was made.   
Case History 
A 35-year-old right-handed Hungarian man presented with one year's history of progressive 
weakness in all four limbs and tremor of the arms.  He had particular difficulties walking, climbing 
stairs and lifting objects above the head, in addition to writing which had deteriorated considerably 
owing to the tremor.  Mild slurring of speech had recently emerged when tired.  After sustaining 
several falls, he began using a stick when walking outdoors six months prior to presentation.  3 
stone in weight had also been lost over this time, despite preserved appetite, with a noticeable loss 
of muscle bulk.  There was no associated pain, sensory or sphincter disturbance, difficulty 
swallowing or breathing, and normal mood and subjective cognition.   
 
Aged 14 the patient had been reviewed by a neurologist regarding difficulty with vertical jumping 
and mild unsteadiness during sports, along with a subtle bilateral hand tremor.  No specific 
diagnosis was made and the symptoms remained static over the next 20 years, although training to 
become an electrician was refused owing to the tremor.  A-Level education was completed in the 
UK before enrolling on a Business degree in the USA but, due to funding issues, was not completed 
and he returned to the UK aged 23.  Thereafter he worked as a carer but had recently stopped due to 
his deteriorating condition.   
 
Past medical history and family history were otherwise unremarkable.  He and his elder brother are 
products of a non-consanguineous marriage without known Jewish ancestry.  His 55-year-old 
mother resides in Latvia but his father died young in a road traffic accident.  Alcohol consumption 
had always been minimal and he had never smoked.   
 
On examination, the cranial nerves, including fundoscopy, were unremarkable except for mild 
bilateral upper motor neuron pattern facial weakness and positive pout reflexes.  Neck flexion and 
extension were normal.  The upper limbs revealed generalised loss of muscle bulk, most markedly 
of triceps bilaterally, with florid fasciculations most visible in pectoralis and deltoid muscles.  A 
coarse, irregular tremor on posture and action was visible throughout the outstretched upper limbs 
with symmetrically slowed alternating movements without past pointing.  Stimulus sensitive 
myoclonus could be elicited on touching the right hand.  Muscle tone was normal whereas power 
revealed disproportionate elbow extension weakness (2/5), along with symmetrical weakness of 
shoulder abduction and external rotation, elbow flexion and the first dorsal interossei (4/5).  All 
other muscle groups had full power including the deep finger flexors.  Reflexes were symmetrically 
brisk including deltoid and supraspinatus jerks on both sides and a right Hoffman sign.  In the lower 
limbs, tone was normal but there was symmetrical weakness of hip flexion (2/5), knee flexion (3/5) 
and knee extension (2/5), but with fully preserved hip extension.  Flexion of the great toes and ankle 
inversion were 4/5 bilaterally with all other muscle groups having full power.  Knee and ankle 
reflexes were symmetrically brisk with bilateral crossed adductors.  Plantar responses were extensor 
but there was no ankle clonus.  Sensory examination was entirely normal.  To rise from a seated 
position he required use of his arms and to lock his knees in extension, before walking with a slow, 
wide-based and waddling gait (see supplementary videos).  Cardiorespiratory, abdominal, skin, 
lymph node and testicular examinations were normal and there was no gynaecomastia.   
 
Blood tests revealed mildly raised CK at 603units/L (NR 0-190). He had normal or negative full 
blood count, renal profile, liver and thyroid function tests, CRP, ESR, ANA, ENA, serum 
immunoglobulin levels, serum protein electrophoresis, anti-neuronal antibodies, anti-ganglioside 
antibodies, HIV, syphilis, Lyme disease and hepatitis A-C serology.   
 
Neurophysiological assessment demonstrated normal peripheral motor and sensory conductions, 
apart from slightly diminished sural sensory action potentials (SAPs) on both sides.  Needle EMG 
was abnormal with widespread chronic denervation including the tongue.   
 
MRI of brain and whole spine showed disproportionate cerebellar atrophy but otherwise normal 
intracranial and cervical cord appearances (Fig. 1).   
 
Lumbar puncture revealed normal CSF opening pressure, white cell count 2 per mm
3
, red cell count 
2 per mm
3
, protein 376mg/L, glucose 3.6mmol/L (paired serum 5.3), normal cytological analysis 
and negative oligoclonal bands.   
 
ECG showed normal sinus rhythm.  CT scan with contrast of chest, abdomen and pelvis revealed no 
visceral abnormality.   
 
Formal neuropsychological assessment was limited by the patient’s writing difficulties.  Out of 14 
sub-component domains he scored within the mildly impaired range in three (visual 
attention/working memory and delayed verbal recall; 21.4%), mild-to-moderate range in six 
(auditory attention/working memory, delayed visual recall, immediate verbal recall, semantic word 
fluency and verbal recognition memory; 42.8%), and moderate-to severe range in two (processing 
speed and immediate visual recall; 14.2%).  In contrast, normal range performance was noted on 
tests of visual perception, confrontational naming, and intellectual ability/non-verbal reasoning 
(21.4%).  Relatively preserved recognition memory suggested difficulty of retrieval rather than 
encoding, while prominent deficits in attention and processing speed suggested a predominantly 
subcortical pattern of impairment.   
Differential Diagnoses 
The patient displayed progressive upper and lower motor neuronopathy without sensory 
involvement raising the possibility of amyotrophic lateral sclerosis.  However, there were atypical 
features including the teenage onset of tremor and sporting difficulties, the predominantly proximal 
pattern of muscle weakness, disproportionate wasting and weakness of triceps muscles, the jerky 
upper limb tremor and myoclonus, and disproportionate cerebellar atrophy.  Beyond cervical 
myelopathy, mimics of ALS with truly mixed motor involvement are rare.
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  Repeat expansions of 
the C9orf72 gene, causative of a spectrum of phenotypes including ALS and frontotemporal 
dementia (FTD), can be associated with regional cerebellar atrophy but penetrance is unusual under 
35 years-of-age and features of FTD were not evident here.
3 4
  Cerebellar atrophy raises the 
possibility of a complex form of autosomal dominant spinocerebellar ataxia, such as SCA 3 
(Machado-Joseph Disease) which can be associated with pyramidal signs and anterior horn cell 
disease.  However, the absence of extraocular movement abnormalities and extrapyramidal signs 
were against this diagnosis.  Although normal appearing white matter on brain MRI would not 
exclude an adult-onset adrenoleukodystrophy, the cerebellar involvement, lack of sphincter 
disturbance or sensory signs and subsequently normal very long chain fatty acids levels rendered 
this and polyglucosan body disease unlikely.  Adult onset Niemann Pick type C may present with a 
myriad of features including cerebellar ataxia and movement disorders although the characteristic 
vertical supranuclear gaze palsy was absent in our case.  Nevertheless, as cerebellar atrophy does 
constitute a recognised feature of this and other GM2 gangliosidoses a white cell enzyme (WCE) 
analysis was undertaken.  This showed normal total hexosaminidase activity at 1210nmol/hr/mg 
(NR 885-5965 and includes Hexosaminidase B activity) but a markedly low white cell β-
Hexosaminidase A functioning at 10nmol/hr/mg (NR 134-700), representing only 15% normal 
hexosaminidase A activity (usually 62-79%).  Genetic testing confirmed the presence of compound 
heterogeneous pathogenic mutations with both 1499T deletion and the 805G>A substitution in the 
HEXA gene.  A definitive diagnosis of late onset Tay-Sachs disease (LOTS) was therefore made.   
Discussion 
β-Hexosaminidase A is a dimeric lysosomal enzyme comprising α and β subunits encoded by the 
HEXA gene on Chromosome 15 and the HEXB gene on Chromosome 5, respectively, and is the 
only one of three isozymes which hydrolyses the ganglioside GM2 into GM3.
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  GM2 belongs to the 
glycosphingolipid category of sphingolipids which are essential constituents of the lipid bilayer of 
cell membranes
7
 and is almost exclusively found in the nervous system, particularly within grey 
matter.
8
  Abnormal accumulation of GM2 within lysozymes is usually precipitated by a deficiency 
of the β-Hexosaminidase A enzyme itself, either due to autosomal recessive gene defects in HEXA 
(Tay Sachs disease) or HEXB (Sandhoff disease) but may arise instead, extremely rarely, due to 
deficiency of its activator protein encoded by the GM2A gene.
9
  The nature of each individual 
clinical presentation is felt to be related to the degree of residual enzyme activity.
5
  Most commonly, 
severe homozygous mutations precipitate little or no functional enzyme activity resulting in 
relentless developmental regression and early death in infancy.
6
  Less severe enzyme defects can 
delay presentation until adolescence or adulthood and produce a rather hetereogeneous disease 
spectrum.  Even in LOTS, however, there is often a history unearthed of subtle motor difficulty in 
childhood.
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  Involvement of neuromuscular weakness, pyramidal signs and cerebellar dysfunction 
is usually evident, as in our case, but also encountered are neuropsychiatric disturbances (in at least 
a third of LOTS with some patients initially believed to have schizophrenia), extrapyramidal 
syndromes, dystonia, overactive bladder symptoms and cognitive decline.
6 7
  The diminished sural 
SAPs demonstrated in our patient have been observed in a subgroup of LOTS patients with a 
clinically-manifest sensory neuropathy,
10
 but would suggest subclinical involvement in our patient.   
 
The nature and extent of cognitive involvement in LOTS is variable with incidence of impaired 
cognition ranging from 0 to 50%.
7 11-13
  Deficits in executive functioning and memory are the most 
commonly reported.  Verbal impairment has been found using computerised testing (Neurotrax).
11
  
An association between the burden of neurological involvement and degree of cognitive 
dysfunction has also been reported.
13
  Formal neuropsychometric testing in our patient 
demonstrated a predominantly subcortical pattern of cognitive impairment with prominent deficits 
in attention, processing speed, executive function, working memory and memory retrieval.  This is 
consistent with neuropathological findings of relatively greater involvement of the subcortical 
structures and cerebellum of individuals with LOTS.
14
   
 
Clinicians should be aware of LOTS as an extremely rare mimic of ALS associated with tremor and 
cerebellar atrophy.  Formal psychometric testing may highlight deficits which are not suspected on 
clinical presentation.  Delineating the extent of cognitive impairment will have an impact on 
multidisciplinary management which remains supportive in the absence of any clinically-effective 
disease modifying treatment for the Hexosaminidase deficiency syndromes.  Although low dose 
pyrimethamine, a dihydrofolate reductase inhibitor, has been shown to mediate a small but 
significant increase in circulating white cell Hexosaminidase A activity in LOTS patients 
possessing certain mutations, the effect appears to wane and even reverse with long term exposure 
which can correct to baseline after a period of drug freedom.
15 16
  Moreover, a small open-label 
study reported that 3 of 4 patients continued to deteriorate over 18 months whereas the other 
remained stable despite a cyclical administration schedule and regular monitoring of WCE 
activity.
15
   
Key Points 
1. Late-onset Tay Sachs (LOTS) disease and adult onset GM2 gangliosidoses are extremely rare 
clinical entities.   
2. Adults presenting with an unusual ALS-type and cerebellar syndrome should prompt 
consideration of (LOTS) and testing of the white cell enzymes looking particularly for 
Hexosaminidase A deficiency.   
3. Patients with LOTS can present with subclinical cognitive deficits that are only present on 
formal neuropsychometric testing and typically reflect subcortical dysfunction.   
4. A longstanding history of subtle clumsiness or athletic difficulties in childhood and teenage 
years may be present. 
5. The only clue from brain imaging may be an isolated cerebellar atrophy.   
Figure 1.  MR brain imaging showing diffuse cerebellar atrophy on sagittal T1 (A), axial T2 (B) 
and coronal T1 (C) sequences with prominence of the cerebellar folia and widening of the fissures 
(arrowheads).   
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